A personalized mRNA vaccine paired with Keytruda may help keep skin cancer from returning after surgery, a large clinical trial suggests.

The treatment multiplies a patient's own immune cells to help them attack melanoma.

A new international study led by Prof. Carmit Levy of the Department of Human Genetics and Biochemistry at the Gray Faculty of Medical & Health Sciences at Tel Aviv University finds that melanoma ...

Medically reviewed byJimmy Almond, M.D. Melanoma is a serious form of skin cancer that starts in melanocytes—the cells that give your skin its color. While it accounts for only about 1 percent of all ...

SAN DIEGO -- Intismeran Autogene, a vaccine that treats melanoma, a deadly type of skin cancer, has made headlines worldwide. Recently reported results indicate that the personalized medication, taken ...

Researchers have created one of the most detailed maps to date of how white blood cells called B cells develop and behave inside melanoma tumors, a type of skin cancer. The study, led by King's ...

The results, announced this week by Moderna and Merck, could pave the way for a new generation of treatments tailored to individual tumors ...

The C-POST trial showed a disease-free survival benefit with adjuvant Libtayo for high-risk cutaneous squamous cell carcinoma, potentially influencing future standard care. Immunotherapy remains the ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A simple skin patch and COVID-like test could soon allow people to test ...

Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.

Older adults face unique risks for skin cancer due to long-term sun exposure and age-related changes. Skin cancer is becoming more common in older adult populations around the world. According to the ...